A detailed history of Cibc Private Wealth Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,532 shares of BIIB stock, worth $241,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,532
Previous 2,571 40.41%
Holding current value
$241,581
Previous $596,000 50.34%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $196,443 - $246,035
-1,039 Reduced 40.41%
1,532 $296,000
Q2 2024

Aug 09, 2024

SELL
$190.52 - $236.72 $20,576 - $25,565
-108 Reduced 4.03%
2,571 $596,000
Q1 2024

May 10, 2024

SELL
$212.02 - $267.71 $6,572 - $8,299
-31 Reduced 1.14%
2,679 $577,000
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $603,218 - $726,117
2,710 New
2,710 $701,000
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $683,656 - $771,617
2,699 New
2,699 $693,000
Q4 2022

Jun 01, 2023

BUY
$252.44 - $306.72 $897,171 - $1.09 Million
3,554 New
3,554 $984,000
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $897,171 - $1.09 Million
3,554 New
3,554 $984,000
Q2 2022

Aug 03, 2022

SELL
$187.54 - $223.02 $207,794 - $247,106
-1,108 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $51,542 - $64,941
-266 Reduced 19.36%
1,108 $233,000
Q4 2021

Feb 08, 2022

BUY
$223.92 - $287.77 $895 - $1,151
4 Added 0.29%
1,374 $330,000
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $128,477 - $167,548
-454 Reduced 24.89%
1,370 $388,000
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $3,885 - $6,220
-15 Reduced 0.82%
1,824 $632,000
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $13,848 - $16,223
57 Added 3.2%
1,839 $514,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $5,197 - $7,823
-22 Reduced 1.22%
1,782 $436,000
Q3 2020

Nov 03, 2020

BUY
$264.77 - $305.71 $477,645 - $551,500
1,804 New
1,804 $512,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $497,403 - $658,723
-1,923 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $69,363 - $87,988
258 Added 15.5%
1,923 $608,000
Q4 2019

Jan 30, 2020

SELL
$220.06 - $304.07 $87,583 - $121,019
-398 Reduced 19.29%
1,665 $494,000
Q3 2019

Oct 16, 2019

SELL
$217.44 - $243.88 $1.13 Million - $1.27 Million
-5,217 Reduced 71.66%
2,063 $480,000
Q2 2019

Jul 31, 2019

SELL
$219.29 - $241.72 $14,911 - $16,436
-68 Reduced 0.93%
7,280 $1.7 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $1.43 Million - $2.24 Million
6,619 Added 907.96%
7,348 $1.74 Million
Q4 2018

Feb 05, 2019

SELL
$278.5 - $352.75 $6.76 Million - $8.56 Million
-24,269 Reduced 97.08%
729 $219,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $950,385 - $1.24 Million
3,238 Added 14.88%
24,998 $8.83 Million
Q2 2018

Aug 02, 2018

BUY
$257.52 - $306.91 $361,558 - $430,901
1,404 Added 6.9%
21,760 $6.32 Million
Q1 2018

May 17, 2018

SELL
$260.13 - $367.91 $12,746 - $18,027
-49 Reduced 0.24%
20,356 $5.57 Million
Q4 2017

Feb 12, 2018

BUY
$307.64 - $344.58 $1.14 Million - $1.28 Million
3,713 Added 22.24%
20,405 $6.5 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $237,290 - $278,258
844 Added 5.33%
16,692 $5.23 Million
Q2 2017

Aug 09, 2017

BUY
N/A
15,848
15,848 $4.3 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.